## **Core Concept**
Diethylstilbestrol (DES) is a synthetic estrogen that was historically prescribed for various conditions, including to prevent miscarriage and ensure fetal well-being. Its use, however, has been associated with significant adverse health effects, particularly related to reproductive health.

## **Why the Correct Answer is Right**
The primary concern with DES use in pregnant women is its association with **clear cell adenocarcinoma of the vagina** and **cervical cancer** in daughters exposed in utero. This rare but aggressive form of vaginal cancer was a significant concern and led to strict limitations on DES use. The mechanism involves the estrogenic effects of DES on the developing fetus, particularly on the reproductive tract, leading to abnormal cell growth patterns.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While DES does have estrogenic effects, the primary concern is not simply its estrogenic activity but its specific impact on fetal development leading to cancer.
- **Option B:** This option might relate to potential effects on the fetus, but it is not specific or directly linked to the known risks associated with DES.
- **Option C:** This option could potentially relate to various drug effects but does not directly address the well-documented risks associated with DES use in pregnancy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **DES exposure in utero is associated with an increased risk of clear cell adenocarcinoma of the vagina and cervix**. This historical use of DES is a classic example of the importance of careful medication use during pregnancy and the long-term consequences for offspring.

## **Correct Answer:** D. Clear cell adenocarcinoma of vagina.